Dose-dependent enhancements by interferon-γ on functional responses of neutrophils from chronic granulomatous disease patients

Blood

Volumn 89, Issue 9, 1997, Pages 3396-3401

  Åhlin, Anders ^a   Blinder, Göran ^a   Palmblad, Jan ^a  

^a SACHS CHILDREN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; RECOMBINANT GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LEUKOCYTE FUNCTION; MALE; NEUTROPHIL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0030941931     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3396     Document Type: Article

References (24)

1. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C: Incidence, severity and prevention of infections in chronic granulomatous disease. J Pediatr 114:555, 1989
2. Speert DP, Bond M, Woodman RC, Cumutte JT: Infection with Pseudoinonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophils in host defense. J Infect Dis 170:1524, 1994
3. 3: Thrasher AJ, Keep NH, Wientjes F, Segal A: Review: Chronic granulomatous disease. Biochim Biophys Acta 1227:1, 1994
4. International Chronic Granulomatous Disease Cooperative Study Group: A controlled trial of Interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509, 1991
5. Weening RS, Leitz GJ, Seger RA: Recombinant human interferon-gamma in patients with chronic granulomatous disease European follow up study. Eur J Pediatr 154:295, 1995
6. Malmvall BE, Follin P: Succesful interferon-gamma therapy in a chronic granulomatous disease (COD) patient suffering from Staphylococcus aureits hepatic abscess and invasive Candida albicans infection. Scand J Infect Dis 25:61, 1993
7. Hague RA, Eastham EJ, Lee REJ, Cant AJ: Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease. Arch Dis Child 69:443, 1993
8. Bernhisel-Broadbent J, Camargo EE, Jaffe HS, Lederman HM: Recombinant human interferon-y as adjunct therapy for Aspergilltts infection in a patient with chronic granulomatous disease. J Infect Dis 163:908, 1991
9. Lekstrom-Himes JA, Holland SM, DeCarlo SE, Miller J, Leitman SF, Chang R, Baker AR, Gallin JI: Treatment with intralesional granulocyte instillations and interferon-y for a patient with chronic granulomatous disease and multiple hepatic abscesses. Clin Infect Dis 19:770, 1994
10. Ezekowitz RAB, Orkin SH, Newburger PE: Recombinant interferon gamma augments phagocyte Superoxide production and chronic granulomatous disease gene expression in X-Iinked variant chronic granulomatous disease. J Clin Invest 80:1009, 1987
11. Ezekowitz RAB, Dinauer MC, Jaffe HS, Stuart HO, Newburger PE: Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 319:146, 1988
12. Ezekowitz RAB, Sieff CA, Dinauer MC, Nathan DO, Orkin SH, Newburger PE: Restoration of phagocyte function by interferony in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood 76:2443, 1990
13. Mühlebach TJ, Gabay J, Nathan CF, Erny C, Dopfer G, Schroten H, Wahn V, Seger RA: Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome bK% content or levels of four anti-microbial proteins. Clin Exp Immunol 88:203, 1992
14. Woodman RC, Erickson RW, Rae J, Jaffe HS, Curnutte JT: Prolonged recombinant interferon-y therapy in chronic granulomatous disease: Evidence against enhanced neutrophil oxidase activity. Blood 79:1558, 1992
15. Maluish AE, Urba WJ, Longo DL, Overton WR, Coggin D, Crisp ER, Williams R, Sherwin SA, Gordon K, Steis RG: The determination of an immunologically active dose of interferongamma in patients with melanoma. J Clin Oncol 3:434, 1988
16. Rex JH, Bennett JE, Gallin JI, Malech HL, DeCarlo ES: In vivo interferon-y therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis 163:849, 1991
17. Huizinga TW, van der School CE, Roos D, Weening R: Induction of neutrophil FC-gamma receptor expression can be used as a marker for biologic activity of recombinant interferon-gamma in vivo. Eur J Clin Invest 21:48, 1991
18. Cassatella MA, Bazzoni F, Calzetti F, Guasparri I, Rossi F, Trinchieri G: Interferon-γ transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human polymorphonuclear leukocytes. J Biol Chem 33:22079, 1991
19. Amezaga MA, Bazzoni F, Sorio C, Rossi F, Cassatella MA: Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon y-dependent gene expression of NADPH oxidase components (gp91-phox, p47phox, and p22-phox) and high affinity receptor for IgG (FcyR-I) in human polymorphonuclear leukocytes. Blood 3:735, 1992
20. Åhlin A, de Boer M, Roos D, Leusen J, Smith CIE, Sundin U, Rabbani H, Palmblad J, Elinder G: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Pediatr 84:1386, 1995
21. Samuelsson J, Hansson A, Rosendahl K, Palmblad J: Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucylphenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera. J Lab Clin Med 121:310, 1993
22. Meerhof LJ, Roos D: Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test. J Leuko Biol 39:699, 1986
23. Jaffe HS, Bucalo LR, Sherwin SA: Anti infective applications of interferon-gamma. New York, NY, Dekker, Inc, 1992
24. Jendrossek V, Damm U, Liese J, Belohradsky BH, Gahr M: Is the IFN-y-induced enhancement of Superoxide production in CGDphagocytes caused by increased expression of the p47-phox cytosolic protein? Immunodefic Rev 4:187, 1993